Indian drug regulator Drugs Controller General of India (DGCI) may consider giving emergency authorisation to Pune-based Serum Institute to make its COVID-19 vaccine available for immunisation in India if the country of origin of the vaccine – UK – approves such a request made by its global license holder AstraZeneca for marketing approval of the Oxford University vaccine developed in the UK.

“We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option)”, Dr Vinod Paul, member Niti Aayog and chairman of the National Expert Group on Vaccine Administration for COVID-19, has said.

Speaking at a virtual panel discussion on “From vaccine to vaccination: Prevention of COVID-19”, on November 21, Dr Paul said the Serum Institute vaccine, undergoing final stage Phase III clinical trials in 16-17 cities in India is the closest in terms of market authorisation among five other vaccines that are undergoing various stages of clinical trials in India.

Also Read: COVID-19 vaccine update: Pfizer files for emergency use; Covaxin trials to start in metro cities

According to Dr Paul, if everything goes by the script, the Phase III clinical trials of Serum vaccine should be over by January/February 2021. An emergency authorisation before that would strengthen the possibility of the vaccine getting administered to the people in the priority list – frontline workers, senior citizens, people with comorbidity etc – early next year.

Also Read : Coronavirus vaccine update: Pfizer applies for emergency approval, 10 things to know

The second vaccine in Phase III clinical trials is the indigenous inactivated virus vaccine jointly developed by ICMR and Bharat Biotech. The third is a DNA COVID-19 vaccine being developed by Zydus Cadilla. The Sputnik V vaccine, the Russian vaccine to be marketed by Dr. Reddy’s, and indigenously developed vaccine using MIT platform by Biological E are the other promising COVID-19 vaccines that are being tested in India, Dr Paul said.

Also read: Covid-19 vaccine: Sputnik V to arrive in India next week for Phase 2,3 clinical trials

On vaccine distribution plans, Dr Paul said the government has the strategy in place and specifics are being worked out in association with the state governments. The government will also make extensive use of its digital platform which will incorporate the list of beneficiaries; send out messages informing them the time and location of vaccination to the beneficiaries, and issue digital certifications based on QR codes. Retired medical practitioners, medical and paramedical students etc may all be roped in to augment the human resource needed to carry out mass vaccination.

The post Oxford COVID-19 vaccine: India may grant SII emergency authorisation if AstraZeneca gets UK govt’s nod appeared first on Ayush Health Guide.

TOP 10 HEALTHCARE COMPANIES IN INDIA 2020

The healthcare institutions play an important role when it comes to look for an effective healthcare solutions. In India, a lot of people suffer from various types of medical conditions and to cope up with it, the Indian healthcare system has left void to serve the people in the best way, even the people suffering from deadliest of diseases. They are always bringing advanced healthcare systems to cater to the increasing requirements of the patients. The better the healthcare institution is, the more better medical support you can avail.

Now for over the years, a lot of healthcare companies have advanced in India and therefore, in today’s age, if you need to go under a surgery, these hospitals are very well-equipped with advanced treatment and procedures to perform any kind of surgery to  make it successful. In older days, people have to travel abroad to avail the best treatments. But, now they can avail the best healthcare treatments in India only and avoid going abroad. The best part of it is that you can now save a lot of money. Here, in this article, you will come to know about the 10 best healthcare companies in India.

List of Top 10 Healthcare Companies in India

The Indian healthcare system has grown a lot in the last few years. People can now avail advanced treatment in India and hence they can avoid going abroad to avail the best treatment. Good doctors and advanced medical procedures are all rapidly improving in this country and are within an affordable range. Let’s take a look at the list of hospitals that have successfully established their brand names across the country.

1. Apollo Hospitals

The first healthcare company on the list is Apollo Hospitals. It has a chain of hospitals spread across the country and in 1983 in Chennai, Dr. It was founded by Pratap Reddy. Apollo offers over 2000 beds across the country. The chain of this hospital is growing rapidly and now in every city you can see Apollo Hospital to serve the people. It is a big name in the healthcare industry. The company is basically a chain of hospitals and they are now developing their own medicines.

2. Fortis healthcare institute

The second name in the list is Fortis Healthcare Institute. This company was established in the year 2001 by Dr. Parvinder Singh. The company has successfully established a chain of hospitals in various cities such as Kolkata, Navi Mumbai, Amritsar, Hyderabad, Jaipur, Mohali, Kota, Chennai, Bengaluru, Guargaon and so on. It is also present in Singapore. It is a brand name in the healthcare industry. The purpose of this company is to establish super specialty hospitals across the world.

3. Wockhardt Ltd

It is basically an Indian company founded in the year 1960 by Mr. Habil Khorakwala. Now it has turned into a global company with its presence in all the developing countries Mexico, Brazil, Russia etc. The company has established its manufacturing plants in many places like UK, US, Ireland and France. This healthcare institute provides state-of-the-art treatment facilities to serve the people of this country. It is a big name in the pharmaceutical industry that manufactures formulations, nutritional products, vaccines and biopharmaceutical items.

Read More:  Benefits of using lemon on face, Hairs – Possible Side effects and more

4. Piramal Enterprise Ltd

The fourth company on the list is Piramal Enterprise. This is a big name in the healthcare industry that was established in 1988 by Ajay Piramal. It has a number of business units such as Piramal Life Sciences, Piramal Healthcare, and Piramal Capital and Resources Group. It is one of the fastest growing healthcare companies in India and has successfully established its various units across the globe.

5. Sun Pharma

Sun Pharma has a presence in over 100 countries worldwide and employs more than 32 thousand employees. Established in the year 1961, this pharmaceutical company has become one of the renowned and leading pharmaceutical manufacturing company in India. In fact, it is by far the largest company in the country and manufactures many medicines for diseases like diabetes, cardiology, neurology etc. The company currently has 48 manufacturing plants where more than 2000 researchers and scientists work. The main business of this pharmaceutical company is to manufacture medicines. It also produces generic drugs.

6. Cipla Limited

Cipla is a well-known pharmaceutical company that manufactures a wide variety of drugs to treat various diseases. The company was founded in the year 1935 by Khwaja Abdul Hameed. Drugs produced by Cipla are used for the treatment of arthritis, cardiovascular diseases, weight control, diabetes, depression and various other health conditions. With its headquarters in Mumbai, Cipla exports its merchandise to more than 150 countries. It has about 34 manufacturing plants where more than 3 billion units of medicines and containers are produced. Not only this, the company is also known for producing antiretroviral drugs that fight dangerous diseases like AIDS and HIV.

Read More:  India will have approved COVID 19 vaccine in early 2021

7. Serum Institute of India

The seventh healthcare company name on the list is Serum Institute of India. The company was founded by Cyrus S. Poonawala and he is also the Chairman of the Board of Directors of this company. It is a leading vaccine manufacturer in the world. Half of the world’s population is immunized by vaccines manufactured by the Serum Institute of India. It is a biotech company that produces low-cost vaccines. The main product of this company is immunobiological vaccines.

8. Lupin Pharmaceutical company

It is one of the leading pharmaceutical manufacturers in India and ranks eight in the list of 10 healthcare companies in India. It is basically a pharmaceutical company with more than 10 manufacturing centers across the country and manufactures a vast range of pharmaceutical products.

9. Dr. Reddy’s Laboratories

It is a multinational pharmaceutical company founded in 1984. The company has successfully established 4 manufacturing units and covers more than 25 countries around the world. The company manufactures medicines for a number of diseases such as cardiovascular diseases, dermatological diseases, gastroenterological diseases, medicines for pediatrics, etc.

10. Siemens healthcare Pvt Ltd

Siemens Healthcare is the last name in our list of top 10 healthcare companies in India. Although it is a German company, the company has a presence in India. It was founded in 1847 by Werner in Berlin. The company manufactures several healthcare systems. There are many hospitals in India that use medical devices manufactured by this company. The company manufactures power generation technology, communication systems, lighting, railway vehicles, medical technology, automation systems.

The post TOP 10 HEALTHCARE COMPANIES IN INDIA 2020 appeared first on Ayush Health Guide.

Essential diet during pregnancy:

Pregnancy Diet Chart is very important for the health of the pregnant woman and her child. Because a healthy Pregnancy food chart only shows the way to reach all the necessary proteins, vitamins, calories, and other minerals to the womb’s body through food in a planned manner.

A correct “Pregnancy Food Guide” should contain detailed guidelines on what you should and should not eat in the morning breakfast, lunch, or lunch. If you want to give birth to a healthy baby, So pay attention to your health. If your health is good then only the child will be healthy!

Therefore, you should choose a healthy diet plan tailored to pregnancy and take your food accordingly, this will help in the transmission of energy in your body as well as other labor-related complications.

So let’s know all the important information related to food in pregnancy with a balanced Pregnancy Diet Chart.

During pregnancy, take plenty of milk, fruits, and vegetables instead of tea and coffee. Avoid eating fried roast Take protein-rich food. And don’t even think of losing weight in the meantime.

It is better to take 200-300 calories more food after conception.

If your diet is balanced, then only you and your child’s health will be safe, so it is necessary to have Folic Acid, Calcium, Iron, Zinc, Protein, Phosphorus, Vitamin D and Omega 3 Omega Fatty Acids in your diet. Taking these elements increases hemoglobin in the blood. And there is no fear of Miss Carriage.

Eat green leafy vegetables, peas, cauliflower, capsicum, almonds, cashews, peanuts, melon, bananas, and oranges as natural sources of all these vitamins. Apart from these, take spinach, beetroot, broccoli, turnip pumpkin rajma dal, curd, fat-free meat, egg whites, milk-whey, cottage cheese, soybeans, beans, and whole grains.

If you eat non-veg food then you should include meat, poultry, fish in your Pregnancy Diet Chart as these are a good source of protein, iron, and zinc. Protein is very important for the formation of body parts. Only one gram of protein per kg of protein per kilogram of the right protein. Suppose if someone weighs 50 kg, they need 50 grams of protein in a normal state, during pregnancy and add 15 grams per day, then a 50 kg pregnant woman should take 65 grams of protein per day.

Oatmeal made of corn, wheat, and other whole grains is rich in fiber, you must include it in your pregnancy diet chart. If you want, you can have popcorn and roasted corn too!

Oat contains fiber, iron, vitamin B, so take a bowl of oats in the morning breakfast.

Milk, yogurt and cheese, and other dairy products are good sources of protein, calcium, phosphorus, and vitamins. Taking these helps in the growth of the child, strengthening his bones and teeth. It helps in the development of muscles and nerves of his heart, taking dairy products apart from building his muscles, kidney function, and heart rate remain normal. Taking these help to make the child’s brain, nervous system, and eyes and avoids the risk of “Postpartum Depression”!

Anemia is often found in Indian women, so doctors advise almost all pregnant women to take more iron. Spinach is rich in iron. This helps in meeting the lack of blood in the pregnant woman’s body, as well as vitamin C also helps in absorbing iron in all the parts of the body so that the pregnant woman can avoid the problems due to anemia. Also helps in better development of the baby. Apart from spinach, iron is also present in plenty of other green vegetables. Apart from this, eat a red pomegranate, guava, pistachios, walnuts, raisins, almonds, amla, etc.

What pregnant women should not eat (Pregnancy diet chart):

• First of all, avoid eating things like coffee, tea, cola-Pepsi, or junk food. The mother’s excessive intake of caffeine has a bad effect on the child’s development.
• Do not eat too much vitamin A, such as liver, sausage, red chili, sweet potato, beet, etc.
• Take pasteurized milk only because by heating the milk at a particular temperature, harmful bacteria are eliminated.
• Avoid flour made of fine flour and other things made from fine flour.
• Consuming sugar-rich foods and excessively spicy food can cause miscarriage.
• These days, avoid eating suramai and sea fish.
• Do not eat undercooked meat or raw eggs or even half-cooked egg is not good, eat only fully cooked egg.
• Do not eat canned juices and readymade packed salads and avoid eating too much oil-ghee. Do not eat raw or semi-cooked food. Do not take mayonnaise also.
• If there is a complaint of constipation during pregnancy, there is no harm in eating papaya. But don’t eat it more than a Bowl!
• Remove junk food like pizza burgers etc. from your Pregnancy diet chart because it fills the stomach immediately, but the body does not get protein and vitamins. The nutritional value of junk food is zero. To know more about catering in pregnancy, read this post on What to eat or not to eat in pregnancy.
• A pregnant woman should always drink clean, filtered, boiled water, or arrange for mineral water. Do not drink the tap water directly, it has a bad effect on health.

Other important tips related to pregnancy diet:

• Pregnancy Diet and Multivitamin Diet Supplements.
• Some pregnant women want to fulfill their deficiency by catering rather than taking medicines, but pregnancy is a time when medicines have to be taken. It is very important to take folic acid.
• Apart from this, it is also possible that despite taking a perfectly balanced diet, your body may be deficient in some Protein, Vitamins, and Minerals, often due to poor health conditions and weak digestion. To overcome this deficiency, your body will need various “Dietary Supplements”, which the doctor will recommend to you after a thorough examination. Do not take them lightly, these are very important! Your doctor will recommend Protein Supplement Powder, Calcium Supplement or Tablets, folic acid supplement, Multivitamin Supplements, and other Optimum Nutrition Supplements that you must take!
• Lack of folic acid can adversely affect the child’s nervous system. Folic acid contributes to the entire development of an unborn baby in the first 28 days, or 3 weeks, of folic acid in advance from the advice of your doctor to protect the fetal infant from the NTDs that affect the fetus. Start taking pills.

The post Pregnancy diet chart – Essential diet during pregnancy appeared first on Ayush Health Guide.

India will have approved COVID 19 vaccine in early 2021

Vaccine Progress:

India is on course to have an “approved” vaccine within the first quarter of calendar year 2021 and Pune- based Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, is well placed to deliver the first vaccine, according to a report out on Thursday from Bernstein Research, a top Wall Street research and brokerage firm.

“Globally, there are four candidates that are close to an approval by the end of the CY2020 or early 2021. Through partnerships India has access to two of those – AZ/Oxford’s viral vector vaccine and Novavax’s protein sub-unit vaccine with AZ/Oxford’s vaccine ahead by a quarter,” says the Bernstein report, which IANS has reviewed.

“With their existing capabilities and capacities SII is best positioned to commercialise one or both of the partnered vaccine candidates depending on approval timing, capacities and pricing.”

Also Read: UK soon to give emergency approval to any COVID-19 vaccine breakthrough

Details:

Data from Phase 1 and Phase trials look promising for both these candidates “in terms of safety and the vaccines ability to elicit an immune response”. The way things look now, the report indicates that both vaccine candidates “will require two doses to be administered 21/28 days apart”.

The report strikes an upbeat tone on India’s “global capacity equation” and does not foresee “manufacturing scale up challenges”.
Serum Institute of India, the report says, could supply 600 million doses in 2021 and 1 billion doses in 2022, out of which 400 to 500 million “should be available in India in 2021” in the context of the company’s commitments to Gavi The Vaccine Alliance and lower and middle income markets.
The report estimates that vaccine volumes will be split 55:45 between the government and private market.

Who will have access to vaccine ?

“We believe the government channel will have first access to the capacities but also believe there will be a sizable private market. In terms of funding, manpower and delivery infrastructure the Government will struggle to shoulder the burden on its own and we expect the private market to step in and supplement.”

Also Read: How effective is CORONIL by Patanjali for COVID-19

Costing:

SII has announced that Gavi will procure vaccines at $3 per dose. The Bernstein report uses that as a benchmark to estimate procurement price to be around $3 a dose for the government and end consumer price of about $6 per dose. Apart from SII, the report lists at least three other Indian pharma companies – Zydus, Bharat Biotech and Biological E – which are working on their own vaccine candidates and are currently in Phase 1 and 2.

Between SII, Bharat Biotech, Biological E, and some smaller players, India produces around 2.3 billion doses of various vaccines every year.
SII alone is the globally largest manufacturer of vaccines with 1.5 billion doses capacity. Every two out of three children globally gets a shot manufactured by SII. In early August, SII entered into a partnership with Gavi, The Vaccine Alliance and the Bill and Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for India and low- and middle-income countries (LMICs).

Atmanirbhar bharat role in vaccine:

If you read the news carefully, they are talking about mass production and supply in 2022. Indians be prepared for being Atma-Nirbhar until then

The collaboration pumps upfront capital to SII to help them increase manufacturing capacity now so that, once a vaccine, or vaccines, gains regulatory approval and WHO prequalification, doses can be produced at scale for distribution to India and lower and middle income nations as quickly as the first half of 2021.

The overall vaccine market in India is estimated at “$6 billion spread over FY 21-22”, according to Bernstein.

The post India will have approved COVID 19 vaccine in early 2021 appeared first on Ayush Health Guide.

UK soon to give emergency approval to any COVID-19 vaccine breakthrough

Legal change will enable population to be immunised as quickly as possible

The government has said that any new and effective COVID vaccine will be given emergency approval for use in the UK and an expanded workforce will be trained to enable more and more people.

A change in the law would allow the UK regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), before being granted temporary approval for the vaccine, as it has been licensed by European authorities, which is a normal procedure.

Also Read: Coronavirus Vaccine Updates:  Oxford’s Covishield Set to provide Vaccine by End of Year in India, Others by Early Next Year

Ministers say this will happen only if the vaccine meets the highest safety and effectiveness standards.

England’s Deputy Chief Medical Officer, Prof Jonathan Van-Tam said: “We are making progress in developing the COVID-19 vaccine, which we hope will save lives, protect health workers and return to normalcy in the future Will be important in.

If we develop effective vaccines, it is important that we make them available to patients as soon as possible but only once safety standards are met. Today’s proposals suggest improved access.

Suggest ways to create and ensure that COVID-19 and many people are protected from the flu and to ensure that any vaccine used is both safe and effective, without sacrificing completely.

In MHRA Unlicensed medicine or vaccine has the power to grant temporary authorization, where a product proves to be safe and effective and is in the patient’s best interest based on available evidence.

A consultation is being started on Friday, which will last for three weeks And health experts and key stakeholder groups Will amend the Human Medicines Regulations 2012 to seek opinion and advice on the proposals.

The post UK soon to give emergency approval to any COVID-19 vaccine breakthrough appeared first on Ayush Health Guide.

फेस मास्क आपकी त्वचा को परेशान कर सकते हैं – इसे कैसे रोकें | फेस मास्क आपकी त्वचा

फेस मास्क आपकी त्वचा को परेशान कर सकते हैं – इसे कैसे रोकें

• मास्क पहनने से अक्सर “मास्क” हो सकता है, जो कि मुंहासे का कारण होता है क्योंकि मास्क में छिद्र होते हैं।
• मास्क पहनने से त्वचा की स्थिति जैसे मोनिएशिया और रोजेसिया भी हो सकती है।
• कम करनेवाला, मॉइस्चराइज़र, और डॉक्टर के पर्चे की दवाएं मास्क को नियंत्रित करने में मदद कर सकती हैं।

सभी डेटा और आँकड़े प्रकाशन के समय सार्वजनिक रूप से उपलब्ध डेटा पर आधारित होते हैं। कुछ जानकारी पुरानी हो सकती है। हमारे कोरोनावायरस हब पर जाएं और COVID-19 के प्रकोप की सबसे हालिया जानकारी के लिए हमारे लाइव अपडेट पेज का अनुसरण करें।

जैसे-जैसे अधिक जगहें खुलने लगती हैं, और मास्क पहनना नियमित हो जाता है, आपकी त्वचा “मास्क” विकसित हो सकती है, इस क्षेत्र में मुँहासे का वर्णन करने के लिए इस्तेमाल किया जाने वाला शब्द एक मुखौटा पहना जाता है।

“[Maskne] हमारे उपन्यास COVID-19 फेस मास्क युग के लिए नए गढ़े गए ‘डर्म-शहरी डिक्शनरी’ शब्द ‘बैकने’ (बैक मुंहासे) पर एक नाटक है। चेस्टेन (सीने में दर्द) कुख्यात शब्द बैकने पर एक पिछला नाटक है, “डॉ। क्रेग क्रैफर्ट, त्वचा विशेषज्ञ और अम्मर्ट स्किन केयर के अध्यक्ष, हेल्थलाइन ने बताया।

उन्होंने कहा कि एक समान मुँहासे प्रतिक्रिया अक्सर हेलमेट पट्टियों के साथ आम है और मुँहासे-प्रवण फुटबॉल खिलाड़ियों और साइकिल चालकों में देखी जाती है।

जॉर्ज वॉशिंगटन यूनिवर्सिटी स्कूल ऑफ मेडिसिन एंड हेल्थ साइंसेज के डर्मेटोलॉजी के प्रोफेसर डॉ। एडम फ्राइडमैन ने हेल्थलाइन को बताया, “यह भी डांसर्स / एक्टर्स (उर्फ मुहांसों के सौंदर्य प्रसाधन) में मोटे मेकअप के साथ देखने के समान है।”

फ्रीडमैन ने कहा कि मरीजों को देखते हुए, पूरे दिन, हर दिन एक मुखौटा पहनने के कारण वह व्यक्तिगत रूप से मुखौटे का अनुभव कर रहे हैं।

“सबसे आम मुद्दा चेहरे की ज्यामितीय वितरण में चेहरे की लालिमा है, सीमा पर सबसे बड़ी प्रमुखता के साथ, इसलिए लोगों को एक सुंदर अंडाकार लाल रूपरेखा मिलती है। ये क्षेत्र आमतौर पर स्पर्श के लिए निविदा होते हैं और कोई भी क्रीम / लोशन स्टिंग लागू करता है, क्योंकि त्वचा की बाधा बाधित हो गई है और सूजन की स्थापना में, संवेदी तंत्रिका बाहरी उत्तेजनाओं के प्रति संवेदनशील हैं, ”उन्होंने कहा।

Also Read: क्या आपको COVID-19 से सुरक्षित रहने के लिए चश्मे पहनने की आवश्यकता है

maskne का क्या कारण है?

जबकि मुँहासे maskne के लिए एक ट्रिगर है, फ्रीडमैन ने कहा कि मास्क पहनने से कुछ स्थितियों के लिए मास्क एक बाल्टी शब्द हो सकता है।

Acne mechanica

शारीरिक हेरफेर और त्वचा पर एक मुखौटा का दबाव मुँहासे को ट्रिगर करता है।

“[साथ] घर्षण, रोड़ा, और COVID-19 के भावनात्मक तनाव का संयोजन … आपके पास मुँहासे के लिए एक आदर्श नुस्खा है। एक पुरानी भड़काऊ बीमारी होने के परिणामस्वरूप पुरानी त्वचा बाधा विघटन के परिणामस्वरूप, त्वचा या सिस्टम पर कोई भी तनाव इस स्थिति को बढ़ा सकता है, ”फ्राइडमैन ने कहा।

क्रैफर्ट सहमत हैं, यह देखते हुए कि तनाव को मुँहासे, एक्जिमा, सेबोरहाइक डर्मेटाइटिस और रोसैसिया के चेहरे की परत को ट्रिगर करने के लिए जाना जाता है।

“जिस मार्ग से तनाव इन परिस्थितियों की ओर जाता है, वह पूरी तरह से समझा नहीं जाता है, लेकिन तनाव के लिए हार्मोनल प्रतिक्रियाएं भूमिका निभा सकती हैं।

मास्क पहनने से त्वचा की विकृतियां खराब हो जाती हैं। साथ में, तनाव और मुखौटे चेहरे की त्वचा के विकारों को खराब करने के लिए सहक्रियाशील रूप से कार्य करते हैं, ”उन्होंने कहा।

Miliaria

Also known as heat rash, miliaria can result from occlusion and sweat under the mask.

“मास्क पहनने से त्वचा में सूक्ष्म परिवर्तन होता है। मास्क के उपयोग के साथ, ढँकी हुई त्वचा को ऊँचे CO2 स्तरों, बढ़ी हुई आर्द्रता, उच्च तापमान और मुंह और श्वसन प्रणाली से अधिक बैक्टीरिया और सूक्ष्मजीवों के अधीन किया जाता है, 

मुँहासे के विपरीत, जो अधिक प्रतिरक्षात्मक रूप से जटिल है,  इनकमिंग प्रणाली से सीधे परिणाम निकलते हैं.  जिससे त्वचा के खुले रोमछिद्रों में फंसी मृत त्वचा कोशिकाओं, जीवाणुओं और पसीने वाले लवणों से छुटकारा मिलता है।

Also Read; How to stay healthy at Home and prevent corona virus ?

Rosacea

फेस मास्क आपकी त्वचा, मुँहासे को भड़काने के अलावा, क्रैफर्ट ने कहा कि मास्क द्वारा त्वचा के माइक्रोबायम में परिवर्तन से रोसेसी | पेरियोरल डर्माटाइटिस बिगड़ सकता है या ट्रिगर हो सकता है, साथ ही सेबोरहाइक डर्मेटाइटिस, स्केलिंग के साथ एक रूसी जैसी चेहरे की लाली हो सकती है।

जबकि rosacea की कुछ विशेषताएं मुँहासे (papulopustules) की नकल कर सकती हैं, Friedman ने कहा कि rosacea अलग है।

“Rosacea एक अद्वितीय पुरानी सूजन की बीमारी है जो त्वचा की बाधा शिथिलता, एक अति सक्रिय स्थानीय प्रतिरक्षा प्रतिक्रिया और रक्त वाहिकाओं के चारों ओर हाइपरसेंसिटिव नसों के परिणामस्वरूप होती है, जिससे उन्हें लगातार चौड़ा होता है, जिसके परिणामस्वरूप चेहरे की लालिमा होती है। बीमारी के बढ़ने के मामले में पूरे दिन मास्क पहनने के साथ भी यही मुद्दे उठते हैं।

The post फेस मास्क आपकी त्वचा को परेशान कर सकते हैं – इसे कैसे रोकें appeared first on Ayush Health Guide.

Corona Test Updates:Portable Device to Detect COVID-19 in an Hour, at Rs 400 by IIT Kharagpur

Indian Institute of Technology Kharagpur said on Saturday that its researchers have developed a portable diagnostic device that can detect COVID-19 infection in 60 minutes at an estimated cost of Rs 400.

This complete non-invasive saliva-based test can be conducted in an ultra Low cost portable enclosure as an alternative to specialized laboratory equipment, IIT Kharagpur said.

The technology essentially depicts a disposable simple paper-strip for chemical analysis and visualization of results.  Results from this new technology strictly verified all established laboratory controls against benchmark.

Results obtained from RT-PCR (reverse transcription polymerase chain) is. Reaction) machine, using synthetic viral RNA, said IIT Kharagpur.

Synthetic RNA is exactly the same as viral RNA extracted from infected patients. “The unique portable device developed by researchers at IIT Kharagpur has been validated not only for the diagnosis of COVID-19, but designed to be able to detect any other type of RNA virus by following the same general procedure .

”Arindam Mondal, assistant professor at the IIT Kharagpur School of Bio Science, said in a statement. “Its effect is, therefore, long-lasting, empowered by the ability to detect unexpected viral epidemics in the coming years, which can repeatedly endanger human life.”

The new device is designed to be usable in places with extremely poor resources. In addition, it can be operated by minimally trained personnel, except for the needs of skilled technicians. IIT Kharagpur professor Suman Chakraborty said.

“RT-PCR-based tests suffer from the need for a detailed laboratory-infrastructure and support system, including operational and maintenance costs, to conduct tests.”

“Alternative current approaches to these tests, on the other hand, are either invasive (blood tests) and non-indicative of the initial stage of infection development, or rely on reagents that are highly volatile and not to be applied in resource-limited Settings. “Said Chakraborty.

If the pilot uses the facility, the equipment developed by researchers at IIT Kharagpur will cost around Rs 2,000.

The same portable unit can be used for a large number of tests. , On the mere replacement of the paper cartridge after each test, the institute said, noting that the device proved to be an inaccurate result with remarkable accuracy and sensitivity in line with standard RT. –

CR test production using a large-scale commercial facility With the increase in scale will further reduce. IIT Kharagpur said that it is ready for commercialization of the product and any corporate or start-up can approach the institute for technology licensing and commercial scale of production.

The post Corona Test Updates:Portable Device to Detect COVID-19 in an Hour, at Rs 400 by IIT Kharagpur appeared first on Ayush Health Guide.

Coronavirus Vaccine Updates:  Oxford’s Covishield Set to provide Vaccine by End of Year in India, Others by Early Next Year

Coronavirus virus vaccine update: After promising results by experimental vaccine candidates from Oxford University and Modern Inc. in preliminary human trials, Covishield has gained significant attention by raising expectations of its initial availability by the end of this year.

However, a World Health Organization (WHO) expert told Reuters that the first batch of COVID-19 vaccines are “realistic” only expected by early 2021.

Many states under lockdown “Many vaccines are now in Phase 3 trials and none have failed, so far, causing immune response In terms of safety or ability to do it.

In reality, this is going to be the first part of next year, before we start seeing people getting vaccinated, “WHO chief, Mike Ryan, quoted Royals Said.

Notably, earlier this week, India launched the experimental COVID-19 vaccine from Oxford and AstraZeneca – ChAdOx1 India has shown a safe and immune response to clinical trials conducted on people between the ages of 18 and 55.

The Pune-based Serum Institute of India, which acquired the production, said that by the end of August Intends to make at least 2-3 million doses for 50 percent of the population.

SII CEO Adar Poon Jawala said, “These vaccines will be for middle and low-income countries in India and around the world.” Poonawalla also confirmed that the vaccine, if successful, will be capped at a price of Rs 1,000 per dose so that all sects And people of the economic classes can afford it.

The post Coronavirus Vaccine Updates:  Oxford’s Covishield Set to provide Vaccine by End of Year in India, Others by Early Next Year appeared first on Ayush Health Guide.

India’s first Corona vaccine update: Covaxin trial begins well in 2 hospitals.

With the increasing number of novel coronavirus cases growing at a daily high in the country for the past few days, COVAXIN, India’s first indigenous COVID-19 vaccine, received approval from the AIIMS Ethics Committee on Saturday to begin human trials from Monday. AIIMS-Delhi is one of the 12 sites selected by the Indian Council of Medical Research (ICMR) for conducting Phase I and II human trials of Covaxin.

In Phase I, the vaccine will be tested on 375 volunteers and maximum of them will be of 100 AIIMS. In addition, the human dose of the vaccine developed by Bharat Biotech India (BBIL), in collaboration with ICMR’s National Institute of Virology (NIV), also started on Wednesday, with the vaccine being given to participants from All India Institute of Medical Sciences, Patna and Pandit Bhagwat. is. Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) in Rohtak, Haryana, a spokesperson said in a statement on Friday, according to the Mint report.

The biotech company received approval from the Drugs Controller General of India (DCGI) earlier this month for human clinical trials.

Here are the major updates that we know about India’s first indigenous COVID-19 vaccine candidate so far:

1) The AIIMS Ethics Committee gave its approval for a human clinical trial starting tomorrow. “Healthy volunteers with no co-morbid conditions and without a history of COVID-19 who are over 18 and under 55 will be eligible to participate in a randomized, double-blind, placebo-controlled clinical trial , “Dr. Sanjay Rai, Professor at the Center for Community Medicine in AIIMS. He said anyone wishing to participate in the trial could send an email to Ctaiims.covid19@gmail.com or call 7428847499.

2) Human trials of COVAXIN have started at All India Institute of Medical Sciences, Patna. AIIMS-Patna selected 10 volunteers to begin human trials of covaxin.

3) AIIMS Patna was the first institute to begin testing on Wednesday and so far around nine people have been vaccinated with a small dose to check for safety, two sources said on condition of anonymity. Sources said that after two weeks, if the vaccine is found to be safe, it will be given to more people.

4) Testing has so far started in AIIMS, Patna, and a few more sites. Earlier, Haryana Health Minister Anil Vij tweeted that human trials with Bharat Biotech’s coronavirus vaccine ov covaxin ‘also started in PGIMS Rohtak. All have tolerated the vaccine very well. There were no adverse efforts, ”Vij tweeted.

5) Sources in Bharat Biotech said that the human clinical trial for COVAXIN was started nationwide with 375 volunteers.

6) COVAXIN has been obtained from a stretch of isolated novel coronaviruses by the National Institute of Virology in Pune. Bharat Biotech developed an “inactive” vaccine at its high-control facility in Gnome Valley, Hyderabad.

7) “Once a vaccine is injected into a human, it has no ability to infect or replicate the infected virus, as it is a killed virus. It just acts on the immune system as a dead virus and An antibody responds to the virus, ”the company said.

8) On Thursday, Microsoft co-founder and philanthropist Bill Gates claimed that the Indian pharmaceutical industry would be able to produce the COVID-19 vaccine not only for the country, but also for the entire world. He said, “India has a lot of potential – with pharmaceutical and vaccine companies that are huge suppliers all over the world. You know that more vaccines are made in India than anywhere – starting with the Serum Institute, that’s the biggest, ” They said.

9) Drug firm Zydus Cadila also said that it has begun human clinical trials of its COVID-19 vaccine candidate ZyCoV-D. In the trial phase, the company will enroll in more than 1,000 subjects at several clinical study sites in India, it said in a regulatory filing.

10) DCGI has allowed two vaccines – one by Bharat Biotech International Limited in collaboration with ICMR and the other by Zydas Cadila Healthcare Ltd to go into Phase I and II human clinical trials.

The post India’s first Corona vaccine update: Covaxin trial begins well in 2 hospitals appeared first on Ayush Health Guide.

Russia to make coronavirus vaccine available to public next month: Report

Amid reports of the world’s first COVID-19 vaccine being injected into Russia for the past few days, the Russian Health Minister said that they would make a coronavirus vaccine candidate, which would be approved by the general public before approving the third and final phase of clinical trials.

Is available for According to a new report. As Sputnik News reported, during a work visit to the central Russian city of Russian government Yekaterinburg, Murasco told reporters, “The government’s decree. It will be imperative that additional clinical research of the approved vaccine be carried out simultaneously Go. ”

According to a Bloomberg report, Kirill Dimitrij, chief executive of the government-backed Russian Direct Investment Fund (RDIF), said researchers in Russia are testing two types of adenovirus vectors to reduce pre-existing immunodeficiency viruses. Effectiveness of the vaccine.

The vaccine will begin phase 3 trials on thousands of people in Saudi Arabia and the United Arab Emirates on August 3 in Russia, Dimitri said. He said that Russia could make a dose of 30 million domestically and 170 million abroad in 2020, with five countries expressing interest in the production of the vaccine and others willing to produce it.

Earlier, the University of Russia’s Sechenov announced that it has successfully completed clinical trials of a coronavirus virus developed by the Gamale Institute of Epidemiology and Microbiology of the Ministry of Defense of Russia.

Alexander Lukashev, director of the Sechenov Institute of Medical Parasitology, Tropical and Vector-Born Diseases, told Sputnik that the tests had established the safety of the vaccine on human health.

It recently approved the first phase of trials in a small group of volunteers. Murasco described the result as “positive”.

In addition, the head of the research institute also stated that the COVID-19 vaccine is “patented and more advanced than Western competitors and would be happy to share the technology with foreign partners, should they need it,” according to reports. The UK, US and Canadian governments have accused the Russian state of hacking international research centers, which are running to develop the COVID-19 vaccine.

In a dramatic statement on Thursday, the UK’s National Cyber ​​Security Center (NCSC) said that in many countries the vaccine and therapeutic areas have been targeted by a group called APT29, stating that it is “definitely” the Russian state. Is part of intelligence. Security agencies US and Canada later issued their own statements supporting the findings, Bloomberg reported. However, the Kremlin has denied the charge.

“Our technology is patented, unique and with standards that I believe exceed the capabilities of tailored products. Being developed in the West,” Gintzberg said, “most probably, if one is to borrow, This will be our vaccination plan to borrow, and we will be happy to share our hack with colleagues should they need to.

”Earlier, the Russian Ministry of Defense clarified that vaccine testing against coronovirus was subject to methodological rules Are being made in full compliance with no efforts to reduce d. Research time.

“The Russian Defense Ministry tested the vaccine on volunteers in compliance with the Working Laws and Scientific Practices Rules to prevent exposure without making any effort to reduce the duration of the research,” the ministry said in a statement. Said in a statement. By Sputnik. President Vladimir Putin has made the vaccine a top priority. Russia has recorded more than 750,000 COVID-19 cases, the fourth most affected country in the world. In Russia’s first race to vaccinate against COVID-19,

it is taking an approach that will be seen in other countries, claiming that it will only know in three months of trials that its prime candidate works or No.

The post Russia to make coronavirus vaccine available to public next month: Report appeared first on Ayush Health Guide.